Home
Mail
Search
News
Finance
Sport
Lifestyle
Celebrity
Movies
Weather
Mobile
More
Yahoo
Mail
Cryptocurrencies
News
Property
Money
Yahoo Finance Invest Asia
Markets
Industries
Watchlists
My Portfolio
My Screeners
Singapore markets closed
Straits Times Index
3,224.01
-27.70
(-0.85%)
Nikkei
40,369.44
+201.37
(+0.50%)
Hang Seng
16,541.42
+148.58
(+0.91%)
FTSE 100
7,952.62
+20.64
(+0.26%)
Bitcoin USD
69,966.78
-892.95
(-1.26%)
CMC Crypto 200
885.54
0.00
(0.00%)
Rhythm Pharmaceuticals, Inc. (RYTM)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
43.33
+1.54
(+3.69%)
At close: 04:00PM EDT
43.33
0.00
(0.00%)
After hours:
07:58PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
77,428
77,428
23,638
3,154
0
Cost of revenue
9,302
9,302
2,133
599
0
Gross profit
68,126
68,126
21,505
2,555
0
Operating expenses
Research development
134,951
134,951
108,630
104,128
90,450
Selling general and administrative
117,532
117,532
92,032
68,486
46,125
Total operating expenses
252,483
252,483
200,662
172,614
136,575
Operating income or loss
-184,357
-184,357
-179,157
-170,059
-136,575
Interest expense
13,892
13,892
5,201
0
0
Total other income/expenses net
190
190
-790
100,000
-
Income before tax
-184,114
-184,114
-181,119
-69,612
-133,996
Income tax expense
564
564
0
0
-
Income from continuing operations
-184,678
-184,678
-181,119
-69,612
-133,996
Net income
-184,678
-184,678
-181,119
-69,612
-133,996
Net income available to common shareholders
-184,678
-184,678
-181,119
-69,612
-133,996
Basic EPS
-3.24
-3.20
-3.47
-1.40
-3.04
Diluted EPS
-3.24
-3.20
-3.47
-1.40
-3.04
Basic average shares
56,952
57,673
52,121
49,600
44,127
Diluted average shares
56,952
57,673
52,121
49,600
44,127
Data Disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Your privacy choices
About Our Ads
© 2024 Yahoo. All rights reserved.